2025
Associations of Medicare Advantage Enrollment Duration with Health Insurance Literacy and Access to and Affordability of Health Care
Elizabeth Staton, Sungchul Park
Journal of General Internal Medicine 2025
Health insurance selection is important for finances and health, but the complex range of available plans, especially in MA, makes this decision challenging. We examined whether beneficiaries with longer MA enrollment had higher health insurance literacy and better access to and affordability of care outcomes than those with shorter enrollment.
Associations of Medicare Advantage Enrollment Duration with Health Insurance Literacy and Access to and Affordability of Health Care
Elizabeth Staton, Sungchul Park
Journal of General Internal Medicine 2025
Health insurance selection is important for finances and health, but the complex range of available plans, especially in MA, makes this decision challenging. We examined whether beneficiaries with longer MA enrollment had higher health insurance literacy and better access to and affordability of care outcomes than those with shorter enrollment.
Racial and Ethnic Inequities in Managing Prescription Drug Costs Among Older Adults in Medicare
Elizabeth Staton, Heeju Sohn
Journal of Racial and Ethnic Health Disparities 2025
We used nationally representative Medicare survey data to evaluate how differences in socioeconomic resources, access to care, health care need, and the use of cost-saving strategies contributed to inequalities in prescription cost burden among older Medicare beneficiaries.
Racial and Ethnic Inequities in Managing Prescription Drug Costs Among Older Adults in Medicare
Elizabeth Staton, Heeju Sohn
Journal of Racial and Ethnic Health Disparities 2025
We used nationally representative Medicare survey data to evaluate how differences in socioeconomic resources, access to care, health care need, and the use of cost-saving strategies contributed to inequalities in prescription cost burden among older Medicare beneficiaries.
2024
GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
Piaopiao Li, Zhiyan Li, Elizabeth Staton, Guillermo E Umpierrez, Georgia Davis, Hui Shao, Francisco J Pasquel
Journal of the American Medical Association 2024
Newer glucose-lowering medications, GLP-1RAs and SGLT2 inhibitors have significant cardiorenal benefits and advantages in weight management. They are not approved specifically for T1D, but some evidence suggests their use in this population. This study used an EHR database of more than half of US residents to explore prescribing trends of these medications for individuals with T1D.
GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
Piaopiao Li, Zhiyan Li, Elizabeth Staton, Guillermo E Umpierrez, Georgia Davis, Hui Shao, Francisco J Pasquel
Journal of the American Medical Association 2024
Newer glucose-lowering medications, GLP-1RAs and SGLT2 inhibitors have significant cardiorenal benefits and advantages in weight management. They are not approved specifically for T1D, but some evidence suggests their use in this population. This study used an EHR database of more than half of US residents to explore prescribing trends of these medications for individuals with T1D.